Somerset Therapeutics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 20	Mar ' 20	Sep ' 19	Sep ' 18	Sep ' 17

Sales

74.97

49.72

35.39

27.27

23.72

Operating profit

7.31

3.88

-1.11

-7.98

-0.82

Interest

1.24

1.39

0.52

0.78

0.40

Gross profit

6.18

5.05

-1.44

-8.24

-1.16

EPS (Rs)

1.16

0.60

-3.66

-10.15

-3.56

Other income

0.11

2.57

0.19

0.52

0.06

Stock adjustment

-0.80

0.17

-0.90

-1.90

-0.80

Raw material

27.17

20.49

16.18

12.10

9.21

Power and fuel

-

-

-

-

-

Employee expenses

15.04

15.54

12.14

10.88

8.50

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

26.25

9.64

9.07

14.16

7.64

Provisions made

-

-

-

-

-

Depreciation

4.57

4.33

2.91

1.97

1.72

Taxation

0.45

0.13

-0.69

-0.03

0.68

Net profit / loss

1.16

0.60

-3.67

-10.18

-3.57

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.02

10.02

10.02

10.02

10.02

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.75

7.80

-3.14

-29.24

-3.44

GPM (%)

8.23

9.67

-4.05

-29.65

-4.90

NPM (%)

1.54

1.15

-10.30

-36.62

-15.00